SCHEMBL18734932

SCHEMBL18734932

CCN(CC)C(=O)C(NC(=O)C(C)C)C(C)(C)SC(=O)CC(=O)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18734940 0.91 METAP2 (0.31) —
SCHEMBL18734943 0.91 — —
SCHEMBL18734928 0.91 — —
SCHEMBL18735144 0.88 — —
SCHEMBL18735190 0.83 MGAM (0.33) —
SCHEMBL18735160 0.83 LMNA (0.31) —
SCHEMBL18735315 0.82 METAP2 (0.36) —
SCHEMBL18734938 0.81 METAP2 (0.30) —
SCHEMBL18734944 0.81 — —
SCHEMBL18734955 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback